The drug contributes to a higher percentage of body-mass weight loss compared to previous weight-loss medications, and accomplishes this more quickly.

Women who take Wegovy to treat obesity have the greatest likelihood of achieving 10% or more weight loss in a year, according to a Cleveland Clinic study published Friday.

In a head-to-head study in the New England Journal of Medicine, people taking Zepbound, Wegovy, Zepbound led to greater weight loss.

Patients who are considering semaglutide for weight loss -- especially women -- might want to factor in hair loss as a possible limitation of this medication, his group advised.

In today’s Health Alert, two popular weight loss drugs went head-to-head in a clinical trial – and one came out on top.

Participants achieved an average weight loss of 20.2% with Zepbound vs. 13.7% with Wegovy In key secondary endpoints, Zepbound was superior to Wegovy across all weight reduction targets and waist ...

Scientists test Mounjaro and Wegovy - the big beasts of weight loss medication - to see which is best.

The drug contributes to a higher percentage of body-mass weight loss compared to previous weight-loss medications, and accomplishes this more quickly.